
Overview
Justin Matulay is a Urologist in Charlotte, North Carolina. Dr. Matulay is highly rated in 16 conditions, according to our data. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Matulay is currently accepting new patients.
His clinical research consists of co-authoring 58 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1021 Morehead Medical Drive, Building 1, Suite 5300, Charlotte, NC 28204
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Atrium Health Levine Cancer Institute (GI/Gastrointestinal Cancer)
Peter Clark is a Urologist in Charlotte, North Carolina. Dr. Clark is highly rated in 24 conditions, according to our data. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Renal Cell Carcinoma (RCC), Cystectomy, and Nephrectomy. Dr. Clark is currently accepting new patients.
Atrium Health Levine Cancer Institute (GI/Gastrointestinal Cancer)
Stephen Riggs is a Urologist in Charlotte, North Carolina. Dr. Riggs is highly rated in 22 conditions, according to our data. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Riggs is currently accepting new patients.
Daniel Watson is a Urologist in Charlotte, North Carolina. Dr. Watson is highly rated in 25 conditions, according to our data. His top areas of expertise are Hydronephrosis, Familial Prostate Cancer, Prostate Cancer, Reconstructive Urology Surgery, and Nephrectomy. Dr. Watson is currently accepting new patients.
Frequently Asked Questions about Dr. Justin T. Matulay
How do I make an appointment with Dr. Justin T. Matulay?
You can book an appointment with Dr. Justin T. Matulay by calling their office at 980-442-6410. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Justin T. Matulay a top-rated expert for Bladder Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Justin T. Matulay is classified as an Elite expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Justin T. Matulay specialize in?
While Dr. Justin T. Matulay is a Urology, they have specific expertise in Bladder Cancer, Muscle Invasive Bladder Cancer, and Urothelial Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.
Does Dr. Justin T. Matulay participate in research or clinical trials?
Yes. Dr. Justin T. Matulay has published 58 articles and abstracts on conditions like Bladder Cancer. You can view a list of Dr. Justin T. Matulay's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Justin T. Matulay accept my insurance?
Dr. Justin T. Matulay accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 980-442-6410 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Bladder CancerDr. Matulay isElite. Learn about Bladder Cancer.
- Distinguished
- CystectomyDr. Matulay isDistinguished. Learn about Cystectomy.
- Muscle Invasive Bladder CancerDr. Matulay isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Matulay isDistinguished. Learn about Non-Muscle Invasive Bladder Cancer.
- Urothelial CancerDr. Matulay isDistinguished. Learn about Urothelial Cancer.
- Advanced
- Chromophobe Renal Cell CarcinomaDr. Matulay isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Matulay isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Matulay isAdvanced. Learn about Familial Wilms Tumor 2.
- NephrectomyDr. Matulay isAdvanced. Learn about Nephrectomy.
- Penile CancerDr. Matulay isAdvanced. Learn about Penile Cancer.
- Prostate CancerDr. Matulay isAdvanced. Learn about Prostate Cancer.
- Experienced
- Bilateral HydronephrosisDr. Matulay isExperienced. Learn about Bilateral Hydronephrosis.
- EmphysemaDr. Matulay isExperienced. Learn about Emphysema.
- EmpyemaDr. Matulay isExperienced. Learn about Empyema.
- EndoscopyDr. Matulay isExperienced. Learn about Endoscopy.
- Familial Prostate CancerDr. Matulay isExperienced. Learn about Familial Prostate Cancer.
- Hemolytic Transfusion ReactionDr. Matulay isExperienced. Learn about Hemolytic Transfusion Reaction.


